Acuamark Diagnostics
Acuamark Diagnostics

Acuamark Diagnostics develops unique technology which allows for highly accurate screening of blood to detect cancer markers at the earliest cancer stages, when cancer is still curable. Backed by highly experienced scientific and industry professionals, it is AcuamarkDx’s mission to detect and attack cancer through accessible, high-precision, early detection. AcuamarkDx’s scientific team is credited with inventing groundbreaking assays such as the ligase chain reaction, the ligase detection reaction, and realtime-PCR. With its lead indication in early colorectal cancer detection, and a pan-cancer early-detection test closely following thereafter, AcuamarkDx’s technology has the opportunity to beneficially impact society on a vast scale.